克林霉素系列产品相关专利情况分布分析数据

通过采集、分析国内克林霉素系列产品的知识产权相关数据，对数据按专利权利人进行归集，统计企业及个人在克林霉素系列产品中拥有的专利总数和专利布局情况和克林霉素系列产品现有专利分布数据，了解国内克林霉素系列产品企业及个人的专利大致情况，计算得到针对不同类型知识产权的数量及占比，以帮助国内克林霉素系列产品研发生产的企业进行知识产权战略制定和申请指导。1、数据采集：通过区域、专利的IPC分类号、专利名称、关键字等信息，由第三方知识产权检索网站检索，对国内克林霉素系列产品相关的授权和审核中的发明专利、实用新型、外观专利的信息进行采集。2、数据处理：对采集到的原始数据进行处理，通过去除重复和有缺失的数据，对数据进行清理分类。3、数据计算：对采集的数据按专利权利人进行归集，统计该专利权利人和国内克林霉素系列产品整体的专利总数，及各类型专利的数量，发明专利数量/专利总数=发明专利占比，实用新型数量/专利总数=实用新型占比，外观专利数量/专利总数=外观专利占比。4、数据应用：根据企业各类专利的比例范围与克林霉素系列产品整体中各类专利占比情况相比较，了解企业专利布局情况，并为企业后续申报专利类型提供指导方向，为不同规模的企业进行知识产权战略制定和申请指导，合理布局专利。

This dataset is developed by collecting and analyzing intellectual property (IP)-related data of domestic clindamycin series products. The data is aggregated by patent assignees, and the total number of patents, patent portfolio layout, and existing patent distribution data of enterprises and individuals related to clindamycin series products are counted, so as to understand the general patent status of domestic enterprises and individuals engaged in clindamycin series products R&D and production. The quantity and proportion of different types of intellectual property are calculated, to help relevant enterprises formulate IP strategies and guide patent applications.
1. Data Collection: Relevant information of granted and pending invention patents, utility model patents, and design patents related to domestic clindamycin series products is retrieved from third-party IP retrieval platforms based on criteria including regions, IPC classification numbers of patents, patent names, and keywords.
2. Data Processing: The collected raw data is processed by removing duplicate and missing records, followed by data cleaning and categorization.
3. Data Calculation: The collected data is aggregated by patent assignees. The total number of patents held by a single assignee and the overall total number of patents in the domestic clindamycin series products market, as well as the quantity of each type of patents, are counted. The proportion of invention patents is calculated as (number of invention patents / total number of patents), the proportion of utility model patents as (number of utility model patents / total number of patents), and the proportion of design patents as (number of design patents / total number of patents).
4. Data Application: By comparing the proportion range of each type of patents held by an enterprise with the overall proportion of corresponding patent types in the domestic clindamycin series products market, the enterprise's patent portfolio layout can be evaluated. This work provides guidance for enterprises to select subsequent patent application types, and offers support for enterprises of all scales to formulate IP strategies and guide patent applications, so as to achieve rational patent layout.

搜集汇总

数据集介绍

特点

该数据集包含629条克林霉素系列产品的专利数据，涵盖发明专利、实用新型和外观专利的数量及占比，主要应用于企业知识产权战略制定和专利申请指导。数据每年更新，并通过浙江省知识产权区块链公共存证平台存证。